Use and limits of (1-3)-β-D-glucan assay (fungitell), compared to galactomannan determination (platelia Aspergillus), for diagnosis of invasive aspergillosis

Journal of Clinical Microbiology

Volumn 52, Issue 7, 2014, Pages 2328-2333

  Sulahian, Annie ^a   Porcher, Raphael ^a   Bergeron, Anne ^a   Touratier, Sophie ^b   Raffoux, Emmanuel ^b   Menotti, Jean ^a   Derouin, Francis ^a   Ribaud, Patricia ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN; BETA LACTAM ANTIBIOTIC; GALACTOMANNAN; ANTIINFECTIVE AGENT; BETA GLUCAN; BETA LACTAM; BETA-1,3-D-GLUCAN; FUNGUS ANTIGEN; MANNAN;

1,3 BETA DEXTRO GLUCAN ASSAY; ACINETOBACTER BAUMANNII; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; APLASTIC ANEMIA; ARTICLE; ASPERGILLUS; BACTEREMIA; BIOASSAY; BLOOD ANALYSIS; BLOOD SAMPLING; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENTEROBACTER FAECALIS; ESCHERICHIA COLI; FALSE POSITIVE RESULT; FINEGOLDIA MAGNA; GALACTOMANNAN TEST; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTION RATE; INFECTION RISK; INTERMETHOD COMPARISON; INVASIVE ASPERGILLOSIS; KLEBSIELLA PNEUMONIAE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MICROCOCCUS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROVIDENCIA ALCALIFACIENS; PSEUDOMONAS AERUGINOSA; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; BLOOD; CHEMISTRY; COMPARATIVE STUDY; COMPLICATION; EVALUATION STUDY; HEMATOLOGIC DISEASE; INVASIVE PULMONARY ASPERGILLOSIS; LABORATORY DIAGNOSIS; SERUM;

ANTI-BACTERIAL AGENTS; ANTIGENS, FUNGAL; BETA-GLUCANS; BETA-LACTAMS; FALSE POSITIVE REACTIONS; HEMATOLOGIC NEOPLASMS; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; MANNANS; SENSITIVITY AND SPECIFICITY; SERUM;

EID: 84903794205     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03567-13     Document Type: Article

References (39)

1. Nucci M, Nouér SA, Cappone D, Anaissie E. 2013. Early diagnosis of invasive pulmonary aspergillosis in hematologic patients: an opportunity to improve the outcome. Haematologica 98:1657-1660. http://dx.doi.org/10.3324/ haematol.2013.094359.
2. Maertens J, Verhagen J, Demuynck H, Brock P, Verhoef G, Vandenbergne P, Van Eldere J, Verbist L, Boogaerts M. 1999. Autopsycontrolled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for haematological patients at risk for invasive aspergillosis. J. Clin. Microbiol. 37:3223-3228. (Pubitemid 29455209)
3. Sulahian A, Boutboul F, Ribaud P, Leblanc T, Lacroix C, Derouin F. 2001. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 91:311-318. http://dx.doi.org/10. 1002/1097-0142(20010115)91:2〈311::AID-CNCR1003〉3.0.CO;2-3.
4. Sulahian A, Touratier S, Ribaud P. 2003. False-positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N. Engl. J. Med. 349:2366-2367. http://dx.doi.org/10.1056/ NEJM200312113492424. (Pubitemid 37509754)
5. Aubry A, Porcher R, Bottero J, Touratier S, Leblanc T, Brethon B, Rousselot P, Raffoux E, Menotti J, Derouin F, Sulahian A. 2006. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with β-lactam antibiotics in patients with haematological disorders. J. Clin. Microbiol. 44:389-394. http://dx.doi.org/10.1128/JCM.44.2. 389-394.2006. (Pubitemid 43222228)
6. Guigue N, Menotti J, Ribaud P. 2013. False positive galactomannan test after ice-pop ingestion. N. Engl. J. Med. 369:97-98. http://dx.doi.org/10.1056/ NEJMc1210430.
7. Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F, Vilard O, Liu KL, Natarajan-Amé S, Lutz P, Dufour P, Bergerat JP, Candolfi E. 2002. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J. Clin. Oncol. 20:1898-1906.http:// dx.doi.org/10.1200/JCO.2002.07.004. (Pubitemid 34273282)
8. De Pauw B, Walsh TJ, Donnely JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WF, Herbrecht R, Hope WW, Kippler CC, Kullberg BJ, Marr KA, Munoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrel TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JF. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46: 1813-1821. http://dx.doi.org/10.1086/588660.
9. Marty FM, Koo S. 2009. Role of (1→3)-β-D-glucan in the diagnosis of invasive aspergillosis. Med. Mycol. 47(Suppl):S233-S240. http://dx.doi.org/10.1080/13693780802308454.
10. Hope WW, Walsh TJ, Denning DW. 2005. Laboratory diagnosis of invasive aspergillosis. Lancet Infect. Dis. 5:609-622. http://dx.doi.org/10.1016/S1473- 3099(05)70238-3. (Pubitemid 41383906)
11. Mennink-Kersten MA, Warris A, Verweij PE. 2006. 1→3-β-D-Glucan in patients receiving intravenous amoxicillin-clavulanic acid. N. Engl. J. Med. 354:2834-2835. http://dx.doi.org/10.1056/NEJMc053340. (Pubitemid 43974215)
12. Kanamori H, Kanemitsu K, Miyazak T, Ameku K, Endo S, Aoyagi T, Inden K, Hatta M, Yamamoto N, Kunishima H, Yano H, Kaku K, Hirakata Y, Kaku M. 2009. Measurement of (1-3)-β-D-lucan derived from different gauze types. Tohoku J. Exp. Med. 217:117-121. http://dx.doi.org/10.1620/tjem.217.117.
13. Kanda H, Kubo K, Hamasak K, Kanda Y, Nakao A, Kitamura T, Fujita T, Yamamoto K, Mimura T. 2001. Influence of various hemodialysis membranes on the plasma (1→3)-β-D-glucan level. Kidney Int. 60:319-323. http://dx.doi.org/10.1046/j.1523-1755.2001.00802.x. (Pubitemid 32587570)
14. Marty FM, Lowry CM, Lempitski SJ, Kubiak DW, Finkelman MA, Baden LR. 2006. Reactivity of (1→3)-β-D-glucan assay with commonly used intravenous antimicrobials. Antimicrob. Agents Chemother. 50: 3450-3453. http://dx.doi.org/10.1128/AAC.00658-06. (Pubitemid 44527523)
15. Racil Z, Kocmanova I, Lengerova M, Weinbergerova B, Buresova L, Toskova M, Winterova J, Timilsina S, Rodriguez I, Mayer J. 2010. Difficulties in using 1,3-β-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies: high frequency of false-positive results and their analysis. J. Med. Microbiol. 59: 1016-1022. http://dx.doi.org/10.1099/jmm.0.019299-0.
16. Nagasawa K, Yano T, Kitabayashi G, Morimoto H, Yamada Y, Ohata A, Usami M, Horiuchi T. 2003. Experimental proof of contamination of blood components by (1,3)-β-D-glucan caused by filtration with cellulose filters in the manufacturing process. J. Artif. Organs 6:49-54. http://dx.doi.org/10.1007/ s100470300008. (Pubitemid 36554087)
17. Theel ES, Doern CD. 2013. β-D-Glucan testing is important for diagnosis of invasive fungal infections. J. Clin. Microbiol. 51:3478-3483. http://dx.doi.org/10.1128/JCM.01737-13.
18. Deeks JJ, Altman DG. 2004. Diagnostic tests 4: likelihood ratios. BMJ 329:168-169. http://dx.doi.org/10.1136/bmj.329.7458.168.
19. Hayden SR, Brown MD. 1999. Likelihood ratio: a powerful tool for incorporating the results of a diagnostic test into clinical decision making. Ann. Emerg. Med. 33:575-580. http://dx.doi.org/10.1016/S0196-0644(99)70346-X. (Pubitemid 29207124)
20. Koo S, Bryar JM, Page JH, Baden LR, Marty FM. 2009. Diagnostic performance of the (1-3)-β-D-glucan assay for invasive fungal disease. Clin. Infect. Dis. 49:1650-1659. http://dx.doi.org/10.1086/647942.
21. Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, Falagas MP. 2011. β-D-Glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin. Infect. Dis. 52:750-770. http://dx.doi.org/10.1093/cid/ciq206.
22. Lamoth F, Cruciani M, Mengoli C, Castagnola E, Lortholary O, Richardson M, Marchetti O, Third European Conference on Infections in Leukemia (ECIL-3). 2012. β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin. Infect. Dis. 54:633-643. http://dx.doi.org/10.1093/ cid/cir897.
23. Pfeiffer CD, Fine JP, Safdar N. 2006. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin. Infect. Dis. 42:1417-1427. http://dx.doi.org/10.1086/503427.
24. Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Scholten RJ, Hooft L, Bijlmer HA, Reitsma JB, Bossuyt PM, Vandenbroucke-Grauls CM. 2008. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst. Rev. (4):CD007394. http://dx.doi.org/10.1002/14651858.CD007394.
25. Ostrosky-Zeichner L, Alexander BD, Kett DH, Vasquez J, Pappas PG, Saek F, Ketchum PA, Wingard J, Schiff R, Tamura H, Finkelman MA, Rex JH. 2005. Multicenter clinical evaluation of the (1→3)-β-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis. 41:654-659. http://dx.doi.org/10.1086/432470. (Pubitemid 41170353)
26. De Vlieger G, Lagrou K, Maertens J, Verbeken E, Meersseman W, Van Wijngaerden E. 2011. β-D-Glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study. J. Clin. Microbiol. 49:3783-3787. http://dx.doi.org/10.1128/JCM.00879-11.
27. Hachem RY, Kontouyiannis DP, Chemaly RF, Jiang Y, Retzel R, Raad I. 2009. Utility of galactomannan enzyme immunoassay and (1,3) β-Dglucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J. Clin. Microbiol. 47:129-133. http://dx.doi.org/10.1128/JCM.00506-08.
28. Kawazu M, Kanda Y, Nannya Y, Aoki K, Kurokawa M, Shiba S, Motokura T, Hirai H, Ogawa S. 2004. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1→3) β-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J. Clin. Microbiol. 42:2733-2741. http://dx.doi.org/10.1128/JCM.42.6.2733-2741.2004. (Pubitemid 38747529)
29. Pazos C, Ponton J, Del Palacio A. 2005. Contribution of (1→3) β-Dglucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic patients: a comparison with serial screening for circulating galactomannan. J. Clin. Microbiol. 43:299-305. http://dx.doi.org/10.1128/JCM.43.1.299-305.2005. (Pubitemid 40096315)
30. Persat F, Ranque S, Derouin F, Michel-Nguyen A, Picot S, Sulahian A. 2008. Contribution of the (1→3)-β-D-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol. 46:1009-1013. http://dx.doi.org/10.1128/JCM.02091-07. (Pubitemid 351379994)
31. Fontana C, Gaziano R, Favaro M, Casalinuovola Pistoia E, Di Fran-cesco P. 2012. (1-3)-β-D-Glucan vs galactomannan antigen in diagnosing invasive fungal infections (IFIs). Open Microbiol. J. 6:70-73. http://dx.doi.org/10.2174/ 1874285801206010070.
32. Metan G, Koç AN, Kaynar LG, Atalay A, Oztürk A, Eser B, Cetin M. 2013. What is the role of the (1→3)-β-D-glucan assay in the screening of patients undergoing autologous haematopoietic stem-cell transplantation? Mycoses 56:34-38. http://dx.doi.org/10.1111/j.1439-0507.2012. 02195.x.
33. Ikemura K, Ikegami K, Shimazu T, Yoshida T, Sugimoto T. 1989. False-positive result in Limulus test caused by Limulus amebocyte lysatereactive material in immunoglobulin products. J. Clin. Microbiol. 27: 1965-1968. (Pubitemid 19208975)
34. Martín-Rabadán P, Gijón P, Alonso Fernández R, Ballesteros M, Anguita J, Bouza E. 2012. False-positive Aspergillus antigenemia due to blood product conditioning fluids. Clin. Infect. Dis. 55:e22-e27. http://dx.doi.org/10.1093/cid/cis493.
35. Pickering JW, Sant HW, Bowles CAP, Roberts WL, Woods GL. 2005. Evaluation of a (1→3)-β-D-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol. 43:5957-5962. http://dx.doi.org/10.1128/JCM.43. 12.5957-5962.2005.
36. Nakao A, Yasui M, Kawagoe T, Tamura H, Tanaka S, Takagi H. 1997. False-positive endotoxemia derives from glucan after hepatectomy for hepatocellular carcinoma with cirrhosis. Hepatogastroenterology 44: 1413-1418. (Pubitemid 27450188)
37. Ellis M, al Ramdi B, Finkelman M, Hedstrom U, Kristensen J, Ali-Zadeh H, Klingspor L. 2008. Assessment of clinical utility of serial β-Dglucan concentrations in patients with persistent neutropenic fever. J. Med. Microbiol. 57:287-295. http://dx.doi.org/10.1099/jmm.0.47479-0. (Pubitemid 351358531)
38. Ansorg R, van den Boom R, Rath PM. 1997. Detection of Aspergillus galactomannan antigen in foods and antibiotics. Mycoses 40:353-357. http://dx.doi.org/10.1111/j.1439-0507.1997.tb00249.x. (Pubitemid 28035279)
39. Racil Z, Kocmanova I, Toskova M, Winterova J, Lengerova M, Timilsina S, Mayer J. 2013. Reactivity of the 1,3-β-D-glucan assay during bacteraemia: limited evidence from a prospective study. Mycoses 56:101-104. http://dx.doi.org/10.1111/j.1439-0507.2012.02210.x.